04.28.17
US Patent No. 9,629,794 B2; Johnson & Johnson Consumer Inc., Skillman, NJ, has been awarded a patent for its composition that is comprised of an NFκB-inhibitor selected from the group consisting of 4-hexyl resorcinol and tetrahydrocurcuminoids; a tropoelastin promoter selected from the group consisting of blackberry extracts and extracts of Phyllanthus niruri; and
a cosmetically-acceptable topical carrier.
a cosmetically-acceptable topical carrier.